Confident
COVERAGE

The Emboliner® Total-Body Embolic Protection System is used during interventional heart procedures to capture and remove embolic debris released into the bloodstream which can cause stroke, cognitive decline, acute kidney injury, and other ischemic complications.

Confident
COVERAGE

The Emboliner® Total-Body Embolic Protection System is used during interventional heart procedures to capture and remove embolic debris released into the bloodstream which can cause stroke, cognitive decline, acute kidney injury, and other ischemic complications.

Protection WITHOUT QUESTION.

The Emboliner sets a new benchmark in embolic protection by offering comprehensive brain and body protection. Its dual-layer Nitinol mesh filter and integrated port are engineered to balance high blood flow with superior debris capture—all in a simple, easy to use system. Fully compatible with leading interventional devices, Emboliner is purpose-built to seamlessly integrate into high-risk transcatheter procedures.

Debris Is Ubiquitous. Ischemic Injury Doesn’t Have to Be.

Debris release during TAVR is not a rare event—it happens in every procedure 1, 2. Early clinical studies with the Emboliner have shown that hundreds to thousands of particles—from calcified valve tissue to thrombus and foreign material—can enter the bloodstream during every procedure 2, 3. Stroke, kidney injury, and other organ damage can be the direct result of where those particles end up.

The odds of embolic injury are not a question of if debris is released—but where it ends up.

Redefining the Scope of Embolic Protection.

The Emboliner is designed to protect beyond the brain—targeting the total embolic burden that challenges interventional heart procedures today. As the field advances toward safer, more complete interventions, total-body protection may become not just ideal, but essential.

Emboline embolic protection

“The Emboliner device is easy to use, integrates well into the TAVR procedure, and offers the potential for full body embolic protection.”

– Tamim Nazif, MD, Director of Clinical Research in Cardiology at Columbia University Irving Medical Center

References:

  • 1 Aggarwal SK, et al. Patterns of solid particle embolization during transcatheter aortic valve implantation and correlation with aortic valve calcification. J Interv Cardiol. 2018 Oct;31(5):648-654.
  • 2 Pasupati S. Clinical Performance of a Total Embolic Protection Device: Results of the Emboliner SafePass 2 Study [abstract]. In: TCT Connect. Oct 14-18, 2020; virtual conference. TCTMD: TCT458.
  • 3 Pasupati S. Capture and Analysis of Debris Generated During TAVR — Can it Inform our Treatment Decisions and Prognoses? [abstract]. In: TCT Connect. Oct 14-18, 2020; virtual conference. TCTMD: TCT454.